Management of coagulation disorders in severe inflammation

Show simple item record Lassila, Riitta Campbell, Robert 2020-01-20T13:45:02Z 2020-01-20T13:45:02Z 2019-06
dc.identifier.citation Lassila , R & Campbell , R 2019 , ' Management of coagulation disorders in severe inflammation ' , Hemasphere , vol. 3 , pp. 95-98 .
dc.identifier.other PURE: 130371236
dc.identifier.other PURE UUID: 3c6c13e6-9d79-498a-9837-26a4aa1332d7
dc.identifier.other WOS: 000501224500037
dc.description.abstract Take home messages To understand the main interplay between coagulation system and inflammation and to recognize the key invasive infectious agents causing typical abnormalities in activation of blood platelets, coagulation and fibrinolysis. To capture, monitor and follow-up the clinical and laboratory phenotype and the management related to the pathophysiology of inflammation. en
dc.format.extent 4
dc.language.iso eng
dc.relation.ispartof Hemasphere
dc.rights cc_by_nc
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject PLATELETS
dc.subject INFECTION
dc.subject FIBRIN
dc.subject CELLS
dc.subject MIP-1-ALPHA
dc.subject ADAMTS13
dc.subject RANTES
dc.subject ROLES
dc.subject 3121 General medicine, internal medicine and other clinical medicine
dc.title Management of coagulation disorders in severe inflammation en
dc.type Article
dc.contributor.organization HUS Comprehensive Cancer Center
dc.contributor.organization Department of Medicine
dc.contributor.organization University Management
dc.contributor.organization Department of Oncology
dc.description.reviewstatus Peer reviewed
dc.relation.issn 2572-9241
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
document_2.pdf 925.9Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record